Related Experiment Video
Updated: Aug 20, 2026

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
Published on: November 16, 2016
Effect of ciprofloxacin on intracellular organisms: in-vitro and in-vivo studies
Abstract:
Ciprofloxacin is taken up rapidly by both human neutrophils and mouse peritoneal macrophages. It does not appear to be bound firmly within the cell and can be eluted readily if the extracellular concentration is lowered. Uptake does not depend on an active transport mechanism. Intracellular ciprofloxacin is biologically active reducing the survival of intracellular Staphylococcus aureus and Mycobacterium fortuitum, in vitro. In vivo, ciprofloxacin was effective in treating a murine systemic infection with an intracellular pathogen Salmonella typhimurium. The progress of infection in sensitive mice with no natural immunity was delayed by ciprofloxacin although at the dosage used the mice were not cured. These results suggested that clinical studies in patients infected by intracellular pathogens are warranted and that ciprofloxacin may have an important role in the treatment of this type of infection.
Insights
Ciprofloxacin rapidly enters immune cells and remains active inside, effectively combating intracellular bacteria like Staphylococcus aureus and Salmonella typhimurium in studies. Further research in patients with intracellular infections is recommended.
Area of Science:
- Pharmacology
- Microbiology
- Immunology
Background:
- Ciprofloxacin is a fluoroquinolone antibiotic.
- Intracellular pathogens pose treatment challenges.
- Understanding ciprofloxacin's cellular behavior is crucial.
Purpose of the Study:
- To investigate ciprofloxacin uptake and activity in phagocytic cells.
- To evaluate the efficacy of ciprofloxacin against intracellular bacteria in vitro and in vivo.
Main Methods:
- Assessing ciprofloxacin uptake in human neutrophils and mouse macrophages.
- Testing the in vitro activity against intracellular Staphylococcus aureus and Mycobacterium fortuitum.
- Evaluating in vivo efficacy in a murine Salmonella typhimurium infection model.
Main Results:
- Rapid ciprofloxacin uptake by neutrophils and macrophages, reversible with decreased extracellular concentration.
- Intracellular ciprofloxacin demonstrated biological activity against intracellular bacteria.
- Ciprofloxacin delayed infection progression in mice with Salmonella typhimurium, though not achieving a complete cure.
Conclusions:
- Ciprofloxacin is readily taken up by immune cells and retains antimicrobial activity intracellularly.
- The drug shows potential for treating infections caused by intracellular pathogens.
- Clinical trials in patients with intracellular infections are warranted.
Related Concept Videos
Methods for Studying Drug Absorption: In vitro
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
Antimicrobial Effectiveness
Inhibitors of Bacterial DNA Synthesis

